Lifestance Stock Based Compensation from 2010 to 2024

LFST Stock

USD 7.52 0.01 0.13%

Lifestance Health Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

99.4 M

Current Value

120.5 M

Quarterly Volatility

83.2 M

Credit Downgrade

Yuan Drop

Covid

Check Lifestance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifestance Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 53 M, Interest Expense of 23.7 M or Selling General Administrative of 293.3 M, as well as many indicators such as Price To Sales Ratio of 2.59, Dividend Yield of 0.0 or PTB Ratio of 2.11. Lifestance financial statements analysis is a perfect complement when working with Lifestance Health Valuation or Volatility modules.

Check out the analysis of Lifestance Health Correlation against competitors.

Latest Lifestance Health's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Lifestance Health Group over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Lifestance Health's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifestance Health's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Lifestance Stock Based Compensation Regression Statistics

	Arithmetic Mean	44,583,791
	Geometric Mean	562,439
	Coefficient Of Variation	186.72
	Mean Deviation	65,123,960
	Median	54,000
	Standard Deviation	83,248,827
	Sample Variance	6930.4T
	Range	259.4M
	R-Value	0.66
	Mean Square Error	4254.3T
	R-Squared	0.43
	Significance	0.01
	Slope	12,206,411
	Total Sum of Squares	97025.1T

Lifestance Stock Based Compensation History

	2024	120.5 M
	2023	99.4 M
	2022	187.4 M
	2021	259.4 M
	2020	1.5 M

Other Fundumenentals of Lifestance Health

Stock Based Compensation To Revenue

Lifestance Health Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.99	0.88	0.9	0.78	-0.77	0.55	0.86	0.97	1.0	0.75	1.0	0.95	0.25	0.8	0.78	0.94	0.25	0.95	-0.87	0.77	0.72	-0.78
Total Stockholder Equity	0.99		0.89	0.89	0.71	-0.73	0.61	0.83	0.94	0.99	0.67	1.0	0.96	0.25	0.86	0.73	0.96	0.25	0.93	-0.89	0.71	0.66	-0.72
Net Tangible Assets	0.88	0.89		0.99	0.5	-0.89	0.72	0.53	0.9	0.85	0.58	0.86	0.97	-0.21	0.87	0.78	0.74	-0.21	0.93	-0.98	0.75	0.71	-0.78
Current Deferred Revenue	0.9	0.89	0.99		0.59	-0.94	0.63	0.59	0.93	0.87	0.67	0.87	0.95	-0.17	0.81	0.86	0.74	-0.17	0.93	-0.96	0.82	0.8	-0.86
Net Debt	0.78	0.71	0.5	0.59		-0.64	-0.02	0.88	0.81	0.77	0.96	0.74	0.57	0.41	0.25	0.82	0.69	0.41	0.73	-0.42	0.84	0.79	-0.82
Retained Earnings	-0.77	-0.73	-0.89	-0.94	-0.64		-0.4	-0.5	-0.88	-0.72	-0.78	-0.72	-0.81	0.31	-0.56	-0.95	-0.55	0.31	-0.86	0.82	-0.92	-0.92	0.95
Accounts Payable	0.55	0.61	0.72	0.63	-0.02	-0.4		0.17	0.44	0.54	-0.06	0.57	0.71	-0.19	0.88	0.26	0.55	-0.19	0.51	-0.75	0.14	0.05	-0.23
Long Term Debt	0.86	0.83	0.53	0.59	0.88	-0.5	0.17		0.78	0.88	0.77	0.86	0.65	0.67	0.48	0.65	0.91	0.67	0.69	-0.53	0.62	0.61	-0.62
Net Receivables	0.97	0.94	0.9	0.93	0.81	-0.88	0.44	0.78		0.94	0.84	0.94	0.94	0.08	0.72	0.87	0.83	0.08	0.99	-0.86	0.9	0.86	-0.88
Good Will	1.0	0.99	0.85	0.87	0.77	-0.72	0.54	0.88	0.94		0.72	1.0	0.93	0.33	0.8	0.75	0.97	0.33	0.92	-0.85	0.72	0.68	-0.73
Total Liab	0.75	0.67	0.58	0.67	0.96	-0.78	-0.06	0.77	0.84	0.72		0.7	0.6	0.18	0.23	0.9	0.59	0.18	0.77	-0.48	0.94	0.93	-0.91
Net Invested Capital	1.0	1.0	0.86	0.87	0.74	-0.72	0.57	0.86	0.94	1.0	0.7		0.94	0.31	0.83	0.73	0.97	0.31	0.92	-0.86	0.71	0.67	-0.72
Total Current Assets	0.95	0.96	0.97	0.95	0.57	-0.81	0.71	0.65	0.94	0.93	0.6	0.94		-0.02	0.91	0.73	0.85	-0.02	0.96	-0.97	0.72	0.67	-0.73
Capital Stock	0.25	0.25	-0.21	-0.17	0.41	0.31	-0.19	0.67	0.08	0.33	0.18	0.31	-0.02		0.01	-0.09	0.51	1.0	-0.01	0.15	-0.12	-0.12	0.13
Net Working Capital	0.8	0.86	0.87	0.81	0.25	-0.56	0.88	0.48	0.72	0.8	0.23	0.83	0.91	0.01		0.42	0.8	0.01	0.76	-0.93	0.38	0.34	-0.41
Short Term Debt	0.78	0.73	0.78	0.86	0.82	-0.95	0.26	0.65	0.87	0.75	0.9	0.73	0.73	-0.09	0.42		0.6	-0.09	0.82	-0.69	0.95	0.93	-1.0
Intangible Assets	0.94	0.96	0.74	0.74	0.69	-0.55	0.55	0.91	0.83	0.97	0.59	0.97	0.85	0.51	0.8	0.6		0.51	0.79	-0.76	0.54	0.5	-0.57
Common Stock	0.25	0.25	-0.21	-0.17	0.41	0.31	-0.19	0.67	0.08	0.33	0.18	0.31	-0.02	1.0	0.01	-0.09	0.51		-0.01	0.15	-0.12	-0.12	0.13
Property Plant Equipment	0.95	0.93	0.93	0.93	0.73	-0.86	0.51	0.69	0.99	0.92	0.77	0.92	0.96	-0.01	0.76	0.82	0.79	-0.01		-0.88	0.87	0.81	-0.84
Short Long Term Debt	-0.87	-0.89	-0.98	-0.96	-0.42	0.82	-0.75	-0.53	-0.86	-0.85	-0.48	-0.86	-0.97	0.15	-0.93	-0.69	-0.76	0.15	-0.88		-0.65	-0.64	0.68
Long Term Debt Total	0.77	0.71	0.75	0.82	0.84	-0.92	0.14	0.62	0.9	0.72	0.94	0.71	0.72	-0.12	0.38	0.95	0.54	-0.12	0.87	-0.65		0.97	-0.97
Capital Surpluse	0.72	0.66	0.71	0.8	0.79	-0.92	0.05	0.61	0.86	0.68	0.93	0.67	0.67	-0.12	0.34	0.93	0.5	-0.12	0.81	-0.64	0.97		-0.95
Deferred Long Term Liab	-0.78	-0.72	-0.78	-0.86	-0.82	0.95	-0.23	-0.62	-0.88	-0.73	-0.91	-0.72	-0.73	0.13	-0.41	-1.0	-0.57	0.13	-0.84	0.68	-0.97	-0.95

Click cells to compare fundamentals

About Lifestance Health Financial Statements

Lifestance Health shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Lifestance Health investors may analyze each financial statement separately, they are all interrelated. The changes in Lifestance Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifestance Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	99.4 M	120.5 M
Stock Based Compensation To Revenue	0.09	0.11

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Lifestance Stock Analysis

When running Lifestance Health's price analysis, check to measure Lifestance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifestance Health is operating at the current time. Most of Lifestance Health's value examination focuses on studying past and present price action to predict the probability of Lifestance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifestance Health's price. Additionally, you may evaluate how the addition of Lifestance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lifestance Stock Based Compensation from 2010 to 2024

Latest Lifestance Health's Stock Based Compensation Growth Pattern

Lifestance Stock Based Compensation Regression Statistics

Lifestance Stock Based Compensation History

Other Fundumenentals of Lifestance Health

Lifestance Health Stock Based Compensation component correlations

About Lifestance Health Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Lifestance Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY